| 000 | 01642 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513151004.0 | ||
| 264 | 0 | _c19980825 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.410440212 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIbarreta, D | |
| 245 | 0 | 0 |
_aDistinct pH homeostatic features in lymphoblasts from Alzheimer's disease patients. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cAug 1998 |
||
| 300 |
_a216-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xpharmacology |
| 650 | 0 | 4 |
_aAcid-Base Equilibrium _xdrug effects |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlzheimer Disease _xmetabolism |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCalmodulin _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytosol _xmetabolism |
| 650 | 0 | 4 |
_aDNA _xanalysis |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin M _ximmunology |
| 650 | 0 | 4 | _aIon Exchange |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aUrcelay, E | |
| 700 | 1 | _aParrilla, R | |
| 700 | 1 | _aAyuso, M S | |
| 773 | 0 |
_tAnnals of neurology _gvol. 44 _gno. 2 _gp. 216-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.410440212 _zAvailable from publisher's website |
| 999 |
_c9674131 _d9674131 |
||